ViroPharma (VPHM)

Add to Watchlists Create an Alert
27.04 +0.60  +2.27%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

ViroPharma Net Interest Income Quarterly:

-3.444M for March 31, 2013
View Full Chart

ViroPharma Net Interest Income Quarterly Chart

    ViroPharma Historical Net Interest Income Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -3.444M
    Dec. 31, 2012 -3.411M
    Sept. 30, 2012 -3.401M
    June 30, 2012 -3.376M
    March 31, 2012 -3.311M
    Dec. 31, 2011 -3.335M
    Sept. 30, 2011 -3.021M
    June 30, 2011 -2.877M
    March 31, 2011 -2.777M
    Dec. 31, 2010 -2.82M
    Sept. 30, 2010 -2.802M
    June 30, 2010 -2.815M
    March 31, 2010 -2.807M
    Dec. 31, 2009 -2.769M
    Sept. 30, 2009 -2.752M
    June 30, 2009 -2.572M
    March 31, 2009 -3.165M
    Dec. 31, 2008 -7.803M
    Sept. 30, 2008 1.639M
    June 30, 2008 2.617M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Interest Income

    Revenues from interest-bearing assets. A typical example would be interest earned by a bank on personal or commercial loans.
    Learn More

    Get data for

    VPHM Net Interest Income Quarterly Benchmarks

    Companies
    Halozyme Therapeutics -0.0132M
    Incyte -11.73M
    Optimer Pharmaceuticals -0.1799M

    VPHM Net Interest Income Quarterly Rankings

    Overall 53rd percentile
    3498 of 7600
    Sector 27th percentile
    474 of 653 in Healthcare
    Industry 23rd percentile
    182 of 238 in Biotechnology

    VPHM Net Interest Income Quarterly Range, Past 5 Years

    Minimum -7.803M Dec 2008
    Maximum 2.617M Jun 2008
    Average -2.750M